Oxurion NV — Director's Dealing 2024

Oct 2, 2024

Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC

Leuven, BELGIUM – October 2, 2024 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation¹ it has received a transparency notifications as follows:

Oxurion received a transparency notification on September 30, 2024, from Atlas Special Opportunities, LLC indicating that as of September 24, 2024, it held 246,783 shares of the then outstanding 1,549,709 shares, and therefore crossed above the threshold (15%) by virtue of the purchase of voting securities. See Annex 1.

Oxurion received a transparency notification on September 30, 2024, from Atlas Special Opportunities, LLC indicating that as of September 26, 2024, it held 231,254 shares of the then outstanding 1,549,709 shares, and therefore crossed below the threshold (15%) by virtue of the sale of voting securities. See Annex 2.

Oxurion received a transparency notification on October 2, 2024, from Atlas Special Opportunities, LLC indicating that as of October 2, 2024, it held 121,000 shares of the then outstanding 1,549,709 shares, and therefore crossed below the threshold (10%) by virtue of the sale of voting securities. See Annex 3.

About Oxurion

Oxurion (Euronext Brussels: OXUR) is engaged in developing next-generation standard of care ophthalmic therapies for the treatment of retinal disease. Oxurion is based in Leuven, Belgium. More information is available at www.oxurion.com.

Important information about forward-looking statements

Certain statements in this press release may be considered "forward-looking". Such forward-looking statements are based on current expectations, and, accordingly, entail and are influenced by various risks and uncertainties. The Company therefore cannot provide any assurance that such forward-looking statements will materialize and does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or any other reason. Additional information concerning risks and uncertainties affecting the business and other factors that could cause actual results to differ materially from any forwardlooking statement is contained in the Company's Annual Report. This press release does not constitute an offer or invitation for the sale or purchase of securities or assets of Oxurion in any jurisdiction. No securities of Oxurion may be offered or sold within the United States without registration under the U.S. Securities Act of 1933, as amended, or in compliance with an exemption therefrom, and in accordance with any applicable U.S. state securities laws.

For further information please contact:

Oxurion NV Pascal Ghoson Chief Executive Officer Pascal.ghoson@oxurion.com

________

^1. Article 14, first paragraph, of the Law of 2 May 2007 on disclosure of major holdings.

ANNEX 1

FSMA	FINANCIAL SERVICES AND MARKETS AUTHORITY		Transparency notification Form TR-1 BE PART I
1) Status of the notification
	Final
2) Issuer
ldentification number 0881-620-924	Name OXURION
3) Reason for the notification
	Acquisition or disposal of voting securities or voting rights
4) Notification by
	A person that notifies alone
5) Persons subject to the notification requirement
	Name		Address (for legal entities)
	Atlas Special Opportunities LLC		2500 Westchester Avenue, Suite 401, Purchase, NY 10577
6) Persons that dispose of voting rights (only to be filled in if art. 7 of the Law applies)
	Name		Address (for legal entities)
2	Please continue entering the information in part II concerning the persons referred to in Sections 5 and 6		Part II
7) Date on which the threshold is crossed
			24/09/2024 (DD/MM/YYYY)
8) Threshold that is crossed (in %)
			15
			If the holding has fallen below the lowest threshold, you have the option of not entering any numbers in Section 10
9) Denominator
		1,549,709
	Please enter the denominator before filling in the data
10) Notified details

A) Voting rights	Previous notification	After the transaction
	# of voting rights	# of voting rights			% of voting rights
Holders of voting rights		Linked to securities	Not linked to the securities	Linked to securities	Not linked to the securities
Atlas Special Opportunities LLC	33,339	246,783		15.92%
	TOTAL	246.783	0	15.92%	0.00%

B) Equivalent financial instruments	After the transaction
Holders of equivalent financial instruments	Type of financial instrument	Expiration date	Exercise period or date	# of voting rights that may be acquired if the instrument is exercised	% of voting rights	Settlement
							+
	TOTAL			0	0.00%
P	The totals will be updated once you have clicked on

TOTAL (A & B)			# of voting rights % of voting rights
	CALCULATE	246,783	15.92%

11) Full chain of controlled undertakings through which the holding is effectively held, if applicable

Atlas Special Opportunities LLC is not a controlled entity.
12) In case of proxy voting for only one GM
	(DD/MM/YYYY)
will cease to hold / 0 voting rights as of Holder will hold again
13) Additional information
On 23 September 2024 with settlement do any and Oppricalities LC aquired 213,444 shares in Curion NV, as a result of which is stares in 240,73 shares (1 15.92%, denominator = 1,549,709).

Done at New York
On	30/09/2024 (DD/MM/YYYY)
Name & capacity Patrick Vance, Proxyholder	Patvick: Varie Signature

For security reasons, the unsigned form in xlsx format should be
transmitted to trp.fin@fsma.be. You can do this manually
OR if you have MS Outlook at your disposal via the "

In addition, a signed copy in PDE format should also be
transmitted.

ANNEX 2

FSMA FINANCIAL SERVICES AND MARKETS AUTHORITY	Transparency notification Form TR-1 BE PART I
1) Status of the notification
Final
2) Issuer
Name OXURION ldentification number 0881-620-924
3) Reason for the notification
Acquisition or disposal of voting securities or voting rights
4) Notification by
A person that notifies alone
5) Persons subject to the notification requirement
Name	Address (for legal entities)
Atlas Special Opportunities LLC	2500 Westchester Avenue, Suite 401, Purchase, NY 10577
6) Persons that dispose of voting rights (only to be filled in if art. 7 of the Law applies)
Name	Address (for legal entities)
Please continue entering the information in part II concerning the persons referred to in Sections 5 and 6 B	Part II
7) Date on which the threshold is crossed
	26/09/2024 (DD/MM/YYYY)
8) Threshold that is crossed (in %)
	15
	If the holding has fallen below the lowest threshold, you have the option of not entering any numbers in Section 10
9) Denominator
	1,549,709
Please enter the denominator before filling in the data
10) Notified details

A) Voting rights Previous notification		After the transaction
	# of voting rights # of voting rights		% of voting rights
Holders of voting rights		Linked to securities	Not linked to the securities	Linked to securities	Not linked to the securities
Atlas Special Opportunities LLC	246,783	231,254		14.92%
TOTAL		231.254	0	14.92%	0.00%

B) Equivalent financial instruments	After the transaction
Holders of equivalent financial instruments	Type of financial instrument	Expiration date	Exercise period or date	# of voting rights that may be acquired if the instrument is exercised	% of voting rights	Settlement
							+
TOTAL				0	0.00%
P The totals will be updated once you have clicked on

TOTAL (A & B)		# of voting rights	% of voting rights
	CALCULATE	231,254	14.92%

11) Full chain of controlled undertakings through which the holding is effectively held, if applicable

	Atlas Special Opportunities LLC is not a controlled entity.
12) In case of proxy voting for only one GM
Holder		will cease to hold / will hold again	0	(DD/MM/YYYY) voting rights as of
13) Additional information
14.92%, denominator = 1,549,709).				On 24 September 2024 (with setterier 2024), Atlas Special Opportunities LC sold 15,29 stares in Ourion NV, as a result of which its stareholing decreased a 23,254 shares (=
	Done at New York
On		30/09/2024 (DD/MMYYYY)
	Name & capacity Patrick Vance, Proxyholder		Signature	Signed by Patvick Vance 948C4780005442

For security reasons, the unsigned form in xlsx format should be
transmitted to trp.fin@fsma_be. You can do this manually
OR if you have MS Outlook at your disposal via th

In addition, a signed copy in PDF format should also be
transmitted.

ANNEX 3

1) Status of the notification Final 2) Issuer Name OXURION ldentification number 0881-620-924 3) Reason for the notification Acquisition or disposal of voting securities or voting rights 4) Notification by A person that notifies alone 5) Persons subject to the notification requirement Name Address (for legal entities) 2500 Westchester Avenue, Suite 401, Purchase, NY 10577 Atlas Special Opportunities LLC 6) Persons that dispose of voting rights (only to be filled in if art. 7 of the Law applies) Name Address (for legal entities) Please continue entering the information in part II concerning the Part II 2 persons referred to in Sections 5 and 6 7) Date on which the threshold is crossed 02/10/2024 (DD/MM/YYYY) 8) Threshold that is crossed (in %) 10 If the holding has fallen below the lowest threshold, you have the option of not entering any numbers in Section 10	FSMA Transparency notification Form TR-1 BE FINANCIAL SERVICES AND PART I MARKETS AUTHORITY
	9) Denominator
1,549,709
Please enter the denominator before filling in the data
	10) Notified details

A) Voting rights	Previous notification	After the transaction
	# of voting rights	# of voting rights		% of voting rights
Holders of voting rights		Linked to securities	Not linked to the securities	Linked to securities	Not linked to the securities
Atlas Special Opportunities LLC	231.254	121.000		7.81%
TOTAL		121,000	0	7.81%	0.00%

B) Equivalent financial instruments	After the transaction
Holders of equivalent financial instruments	Type of financial instrument	Expiration date	Exercise period or date	# of voting rights that may be acquired if the instrument is exercised	% of voting rights	Settlement
							+
TOTAL			0	0.00%
The totals will be updated once you have clicked on P
TOTAL (A & B)			# of voting rights	% of voting rights

CALCULATE

121,000

7.81%

11) Full chain of controlled undertakings through which the holding is effectively held, if applicable

	Atlas Special Opportunities LLC is not a controlled entity.
12) In case of proxy voting for only one GM
Holder		will cease to hold / will hold again	0	voting rights as of	(DD/MM/YYYY)
13) Additional information
13.77%, denominator = 1,549,709). 13.00%, denominator = 1,549,709). 12.26%, denominator = 1,549,709). denominator = 1,549,709).	On 25 September 2024, Nas Special Openinies LC sol 17, 10 Stares in Orunn N. as result which its stressed by 21, 44 shares = On 25 September 2024 (with settener date on 27 September LC sold 1,961 shares in Oruinn N. as a result of which its starebring decreased b 20143 share= On 26 September 2024 with still on 30 September 2024, Mas Special Opportunities LC sold 1 with its stranbling becreased b 190,000 starse (a 190,000 starse (a On 30 Section of the etterner date on 2 October 2024, Atlas Special Operation N. as a result of which its starest of 121,000 stares (-7 1%
	Done at New York
On		02/10/2024 (DD/MMYYYY)
	Name & capacity Patrick Vance, Proxyholder		Signature Signature	-Signed by Patrile Vasse -9A8C4789B05442E

For security reasons, the unsigned form in xlsx format should be
transmitted to trp.fin@fsma.be. You can do this manually
OR if you have MS Outlook at your disposal via th

In addition, a signed copy in PDE format should also be
transmitted.